FETAL AND NEONATAL HAZARDS FROM DRUGS ADMINISTERED DURING PREGNANCY.
D000014:Abnormalities, Drug-Induced; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000963:Antimetabolites; D000970:Antineoplastic Agents; D013956:Antithyroid Agents; D005260:Female; D005315:Fetal Diseases; D005333:Fetus; D006461:Hemolysis; D006728:Hormones; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012110:Reserpine; D012459:Salicylates; D013792:Thalidomide; D014044:Tolbutamide; D014812:Vitamin K
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000963:Antimetabolites; D000970:Antineoplastic Agents; D013956:Antithyroid Agents; D006728:Hormones; D012459:Salicylates; D014812:Vitamin K; D013792:Thalidomide; D012110:Reserpine; D014044:Tolbutamide
ABNORMALITIES, DRUG-INDUCED; ANTIBIOTICS; ANTICOAGULANTS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; FETAL DISEASES; HEMOLYSIS; HORMONES; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL-FETAL EXCHANGE; PREGNANCY; RESERPINE; REVIEW; SALICYLATES; THALIDOMIDE; THYROID ANTAGONISTS; TOLBUTAMIDE; VITAMIN K